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ABSTRACT

The focus of this study was to analyze the presence of toxin
genes from Staphylococcus aureus, such as alpha toxin and
toxic shock syndrome toxin-1 (TSST-1). The bacteria’s
genomic DNA was amplified via Polymerase Chain Reaction
(PCR) and visualized through DNA gel electrophoresis.
Clinical isolates that were known to be positive for the
specific toxin genes were used as positive controls.

ALL STAPHLYLOCOCCUS AUREUS
SAMPLES TESTED POSITIVE FOR
ALPHA TOXIN.

WHY STAPH?
S. aureus is commonly found on the skin and in the nose. About
30% of healthy adults carry S. aureus in their nose and about 20%
on their skin (Tenover, 2008). Many people can carry it without
any symptoms; however it can become dangerous when it
enters the body. It most commonly causes skin infections, but it
can also cause infections of the heart, lungs, bones, and blood.
All of which could be life threatening. Understanding the
prevalence of these toxic genes that cause illness can help lead
to greater discoveries of the pathogenesis of S. aureus.

VIRULENCE FACTORS
S. aureus toxins can be divided into three major groups:
• Pore forming toxins (PFTSs)
• Exfoliative toxins (ETs)
• Superantigens (SAgs)
Alpha toxin is a pore-forming toxin and TSST-1 is a superantigen.
The function of these toxin genes includes degrading the host
cells, manipulating the immune responses, and degrading
intercellular junctions (Oliveira 2018). All these functions assist in S.
aureus proliferation and disease.

STUDY OVERVIEW

Our data collection so far for nasal carriage rate of S. aureus
is displayed in the charts below:

ALPHA TOXIN
Alpha toxin can be found in 95% of clinical S. aureus strains
(Oliveira 2018). Alpha toxin is a major cytotoxic agent that causes
cell lysis. It does this by forming pores into the host’s cell
membrane, eventually causing cell death. It also alters cell
signaling pathways including cell proliferation, inflammatory
responses, cytokine secretion, and cell-cell interactions. This toxin
has been demonstrated to affect many human cells including
epithelial cells, endothelial cells, T cells, monocytes, and
macrophages (Hildebrand 1991).

METHODS

Polymerase Chain Reaction (PCR):

• PCR was used to amplify
target genes like Alpha
toxin and TSST-1.
• Annealing temperatures:
• Alpha Toxin: 57°C
• TSST-1: 57°C

DNA Gel Electrophoresis:
• Gel electrophoresis was used to
separate the DNA mixture based
on molecular size in base pairs
(bp).
• A 2% agarose gel was created
for each gel run.

RESULTS
12 S. aureus samples were collected from human nostrils
and tested for alpha toxin and TSST-1. All 12 samples tested
positive for alpha toxin, while only 3 samples tested positive
for TSST-1.

TSST-1

Gel electrophoresis of alpha toxin from S. aureus. Positive control
was a known clinical isolate MNPE that carries the alpha toxin
gene. Negative control contains the forward and reverse primer
for alpha toxin with no genomic DNA.

TSST-1 is one of the many superantigens S. aureus can produce.
TSST-1 is known for causing both menstrual and nonmenstrual toxic
shock syndrome (TSS). The symptoms of TSS include high fever, low
blood pressure, vomiting, and a skin rash. As a superantigen, TSST1 alters the host’s immune response by binding to both the
antigen presenting cell and the T cell. This triggers a massive
cytokine release, as well as a large production of T cells and
monocytes (Wahlsten 2020). This causes
a “false” immune response by the host,
which is one of the many mechanisms
of S. aureus to survive and cause
detrimental diseases like TSS and sepsis.
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